From Armshares Charles Breeze today.
The appeal to me of solutions companies is their ability to deliver attractive and sustainable returns - my favourite investment in 2006 has been Immunodiagnostic Systems Holdings, which listed in December 2004 at 51p, achieved 100p by December 2005 and stands at 224p today, having declared a maiden dividend. In my opinion, IDS has a team and a strategy which make this a very attractive business, so despite the rise, I still don't feel minded to sell.